Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Comment by eunice12on Jun 27, 2015 1:28am
356 Views
Post# 23873633

RE:RE:RE:60 million cash and a promising lead drug

RE:RE:RE:60 million cash and a promising lead drugCanaccord below assumes only 30% chance of success. Do you realize what happens to your money if the 70% occurs, and how much bigger 70 is than 30? Insane risk - consider how many slam dunk medical devices you can buy into nowadays with super low risk.

"Assuming a probability of success of 30%, a royalty rate of
12% on peak revenues, and a discount rate of approximately 15%, we calculate a NPV
of $3.26 on a per share basis."

<< Previous
Bullboard Posts
Next >>